Conjugated bisphenol A in maternal serum in relation to miscarriage risk

Ruth B. Lathi, Cara A. Liebert, Kathleen Brookfield, Julia A. Taylor, Frederick S. Vom Saal, Victor Y. Fujimoto, Valerie L. Baker

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objective To examine the relationship between the maternal serum bisphenol A (BPA) concentration at the time of the missed menstrual cycle and miscarriage risk. Design Retrospective cohort of prospectively collected serum samples. Setting Academic fertility center. Patient(s) Women presenting for early pregnancy monitoring with singleton pregnancies. Intervention(s) Stored serum samples from 4 to 5 weeks' gestation analyzed for conjugated serum BPA concentrations. Main Outcome Measure(s) Live birth, miscarriage, and chromosome content of miscarriage. Result(s) With the 115 women included in the study, there were 47 live births and 68 clinical miscarriages (46 aneuploid and 22 euploid). Median conjugated BPA concentrations were higher in the women who had miscarriages than in those who had live births (0.101 vs. 0.075 ng/mL). Women with the highest quartile of conjugated BPA had an increased relative risk of miscarriage (1.83; 95% CI, 1.14-2.96) compared with the women in the lowest quartile. We found a similar increase risk for both euploid and aneuploid miscarriages. Conclusion(s) Maternal conjugated BPA was associated with a higher risk of aneuploid and euploid miscarriage in this cohort. The impact of reducing individual exposure on future pregnancy outcomes deserves further study.

Original languageEnglish (US)
Pages (from-to)123-128
Number of pages6
JournalFertility and Sterility
Volume102
Issue number1
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Spontaneous Abortion
Mothers
Serum
Live Birth
Aneuploidy
Pregnancy
bisphenol A
Pregnancy Outcome
Menstrual Cycle
Fertility
Chromosomes
Outcome Assessment (Health Care)

Keywords

  • Aneuploidy
  • bisphenol A
  • endocrine disruptor
  • miscarriage
  • pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Lathi, R. B., Liebert, C. A., Brookfield, K., Taylor, J. A., Vom Saal, F. S., Fujimoto, V. Y., & Baker, V. L. (2014). Conjugated bisphenol A in maternal serum in relation to miscarriage risk. Fertility and Sterility, 102(1), 123-128. https://doi.org/10.1016/j.fertnstert.2014.03.024

Conjugated bisphenol A in maternal serum in relation to miscarriage risk. / Lathi, Ruth B.; Liebert, Cara A.; Brookfield, Kathleen; Taylor, Julia A.; Vom Saal, Frederick S.; Fujimoto, Victor Y.; Baker, Valerie L.

In: Fertility and Sterility, Vol. 102, No. 1, 2014, p. 123-128.

Research output: Contribution to journalArticle

Lathi, RB, Liebert, CA, Brookfield, K, Taylor, JA, Vom Saal, FS, Fujimoto, VY & Baker, VL 2014, 'Conjugated bisphenol A in maternal serum in relation to miscarriage risk', Fertility and Sterility, vol. 102, no. 1, pp. 123-128. https://doi.org/10.1016/j.fertnstert.2014.03.024
Lathi, Ruth B. ; Liebert, Cara A. ; Brookfield, Kathleen ; Taylor, Julia A. ; Vom Saal, Frederick S. ; Fujimoto, Victor Y. ; Baker, Valerie L. / Conjugated bisphenol A in maternal serum in relation to miscarriage risk. In: Fertility and Sterility. 2014 ; Vol. 102, No. 1. pp. 123-128.
@article{cf72d50c6e2a4a4d87c24bfaa2fb7e80,
title = "Conjugated bisphenol A in maternal serum in relation to miscarriage risk",
abstract = "Objective To examine the relationship between the maternal serum bisphenol A (BPA) concentration at the time of the missed menstrual cycle and miscarriage risk. Design Retrospective cohort of prospectively collected serum samples. Setting Academic fertility center. Patient(s) Women presenting for early pregnancy monitoring with singleton pregnancies. Intervention(s) Stored serum samples from 4 to 5 weeks' gestation analyzed for conjugated serum BPA concentrations. Main Outcome Measure(s) Live birth, miscarriage, and chromosome content of miscarriage. Result(s) With the 115 women included in the study, there were 47 live births and 68 clinical miscarriages (46 aneuploid and 22 euploid). Median conjugated BPA concentrations were higher in the women who had miscarriages than in those who had live births (0.101 vs. 0.075 ng/mL). Women with the highest quartile of conjugated BPA had an increased relative risk of miscarriage (1.83; 95{\%} CI, 1.14-2.96) compared with the women in the lowest quartile. We found a similar increase risk for both euploid and aneuploid miscarriages. Conclusion(s) Maternal conjugated BPA was associated with a higher risk of aneuploid and euploid miscarriage in this cohort. The impact of reducing individual exposure on future pregnancy outcomes deserves further study.",
keywords = "Aneuploidy, bisphenol A, endocrine disruptor, miscarriage, pregnancy",
author = "Lathi, {Ruth B.} and Liebert, {Cara A.} and Kathleen Brookfield and Taylor, {Julia A.} and {Vom Saal}, {Frederick S.} and Fujimoto, {Victor Y.} and Baker, {Valerie L.}",
year = "2014",
doi = "10.1016/j.fertnstert.2014.03.024",
language = "English (US)",
volume = "102",
pages = "123--128",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Conjugated bisphenol A in maternal serum in relation to miscarriage risk

AU - Lathi, Ruth B.

AU - Liebert, Cara A.

AU - Brookfield, Kathleen

AU - Taylor, Julia A.

AU - Vom Saal, Frederick S.

AU - Fujimoto, Victor Y.

AU - Baker, Valerie L.

PY - 2014

Y1 - 2014

N2 - Objective To examine the relationship between the maternal serum bisphenol A (BPA) concentration at the time of the missed menstrual cycle and miscarriage risk. Design Retrospective cohort of prospectively collected serum samples. Setting Academic fertility center. Patient(s) Women presenting for early pregnancy monitoring with singleton pregnancies. Intervention(s) Stored serum samples from 4 to 5 weeks' gestation analyzed for conjugated serum BPA concentrations. Main Outcome Measure(s) Live birth, miscarriage, and chromosome content of miscarriage. Result(s) With the 115 women included in the study, there were 47 live births and 68 clinical miscarriages (46 aneuploid and 22 euploid). Median conjugated BPA concentrations were higher in the women who had miscarriages than in those who had live births (0.101 vs. 0.075 ng/mL). Women with the highest quartile of conjugated BPA had an increased relative risk of miscarriage (1.83; 95% CI, 1.14-2.96) compared with the women in the lowest quartile. We found a similar increase risk for both euploid and aneuploid miscarriages. Conclusion(s) Maternal conjugated BPA was associated with a higher risk of aneuploid and euploid miscarriage in this cohort. The impact of reducing individual exposure on future pregnancy outcomes deserves further study.

AB - Objective To examine the relationship between the maternal serum bisphenol A (BPA) concentration at the time of the missed menstrual cycle and miscarriage risk. Design Retrospective cohort of prospectively collected serum samples. Setting Academic fertility center. Patient(s) Women presenting for early pregnancy monitoring with singleton pregnancies. Intervention(s) Stored serum samples from 4 to 5 weeks' gestation analyzed for conjugated serum BPA concentrations. Main Outcome Measure(s) Live birth, miscarriage, and chromosome content of miscarriage. Result(s) With the 115 women included in the study, there were 47 live births and 68 clinical miscarriages (46 aneuploid and 22 euploid). Median conjugated BPA concentrations were higher in the women who had miscarriages than in those who had live births (0.101 vs. 0.075 ng/mL). Women with the highest quartile of conjugated BPA had an increased relative risk of miscarriage (1.83; 95% CI, 1.14-2.96) compared with the women in the lowest quartile. We found a similar increase risk for both euploid and aneuploid miscarriages. Conclusion(s) Maternal conjugated BPA was associated with a higher risk of aneuploid and euploid miscarriage in this cohort. The impact of reducing individual exposure on future pregnancy outcomes deserves further study.

KW - Aneuploidy

KW - bisphenol A

KW - endocrine disruptor

KW - miscarriage

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84903376251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903376251&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2014.03.024

DO - 10.1016/j.fertnstert.2014.03.024

M3 - Article

C2 - 24746738

AN - SCOPUS:84903376251

VL - 102

SP - 123

EP - 128

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -